Your browser doesn't support javascript.
Changing patterns of urologic emergency visits and admissions during the COVID-19 pandemic: a retrospective, multicenter, nationwide study.
Rajwa, Pawel; Przydacz, Mikolaj; Krajewski, Wojciech; Kuffel, Blazej; Zapala, Piotr; Krzywon, Aleksandra; Cortez, Alexander J; Dybowski, Bartosz; Stamirowski, Remigiusz; Jarzemski, Marcin; Drobot, Rafal B; Stelmach, Pawel; Mlynarek, Krystyna; Marcinek, Mateusz; Przudzik, Maciej; Krawczyk, Wiktor; Ryszawy, Jakub; Choragwicki, Dominik; Zapala, Lukasz; Lipa, Marcin; Pozniak, Michal; Janczak, Dawid; Slomian, Szymon; Laszkiewicz, Jan; Nowak, Marcel; Miszczyk, Marcin; Roslan, Marek; Tkocz, Michal; Zdrojowy, Romuald; Potyka, Andrzej; Szydelko, Tomasz; Drewa, Tomasz; Jarzemski, Piotr; Radziszewski, Piotr; Slojewski, Marcin; Antoniewicz, Artur; Paradysz, Andrzej; Chlosta, Piotr L.
  • Rajwa P; Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Przydacz M; Department of Urology, Jagiellonian University Medical College, Krakow, Poland.
  • Krajewski W; Department of Urology and Urological Oncology, Wroclaw Medical University, Wroclaw, Poland.
  • Kuffel B; Department of General and Oncological Urology, 1 University Hospital, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Zapala P; Department of General, Oncological and Functional Oncology, Medical University of Warsaw, Warsaw, Poland.
  • Krzywon A; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Cortez AJ; Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Dybowski B; Department of Urology, Roefler Memorial Hospital, Pruszkow, Poland.
  • Stamirowski R; Department of Urology and Urological Oncology, Pomeranian Medical University, Szczecin, Poland.
  • Jarzemski M; Department of Urology, Jan Biziel University Hospital in Bydgoszcz, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Poland.
  • Drobot RB; Department of Urology and Urological Oncology, Multidisciplinary Hospital in Warsaw-Miedzylesie, Warsaw, Poland.
  • Stelmach P; Clinical Department of Urology, 4 Clinical Military Hospital, Wroclaw, Poland.
  • Mlynarek K; Division of Oncology and Palliative Care, Faculty of Health Sciences, Wroclaw Medical University, Poland.
  • Marcinek M; Urological Ward, Independent Public Health Care Unit, Voivodeship Specialised Hospital No. 3, Rybnik, Poland.
  • Przudzik M; Department of Urology, FMS in Katowice, Medical University of Silesia, Katowice, Poland.
  • Krawczyk W; University of Warmia and Mazury, Faculty of Medicine, Department of Urology, Olsztyn, Poland.
  • Ryszawy J; Department of Urology and Urological Oncology, Pomeranian Medical University, Szczecin, Poland.
  • Choragwicki D; Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Zapala L; Department of Urology, Jagiellonian University Medical College, Krakow, Poland.
  • Lipa M; Department of General, Oncological and Functional Oncology, Medical University of Warsaw, Warsaw, Poland.
  • Pozniak M; Department of Urology and Urological Oncology, Multidisciplinary Hospital in Warsaw-Miedzylesie, Warsaw, Poland.
  • Janczak D; Department of General and Oncological Urology, 1 University Hospital, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Slomian S; Clinical Department of Urology, 4 Clinical Military Hospital, Wroclaw, Poland.
  • Laszkiewicz J; Division of Oncology and Palliative Care, Faculty of Health Sciences, Wroclaw Medical University, Poland.
  • Nowak M; Urological Ward, Independent Public Health Care Unit, Voivodeship Specialised Hospital No. 3, Rybnik, Poland.
  • Miszczyk M; Department of Urology and Urological Oncology, Wroclaw Medical University, Wroclaw, Poland.
  • Roslan M; Department of Urology, FMS in Katowice, Medical University of Silesia, Katowice, Poland.
  • Tkocz M; Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Zdrojowy R; University of Warmia and Mazury, Faculty of Medicine, Department of Urology, Olsztyn, Poland.
  • Potyka A; Department of Urology, FMS in Katowice, Medical University of Silesia, Katowice, Poland.
  • Szydelko T; Department of Urology and Urological Oncology, Wroclaw Medical University, Wroclaw, Poland.
  • Drewa T; Urological Ward, Independent Public Health Care Unit, Voivodeship Specialised Hospital No. 3, Rybnik, Poland.
  • Jarzemski P; Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Radziszewski P; Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Slojewski M; Division of Oncology and Palliative Care, Faculty of Health Sciences, Wroclaw Medical University, Poland.
  • Antoniewicz A; Department of General and Oncological Urology, 1 University Hospital, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Paradysz A; Department of Urology, Jan Biziel University Hospital in Bydgoszcz, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Poland.
  • Chlosta PL; Department of General, Oncological and Functional Oncology, Medical University of Warsaw, Warsaw, Poland.
Arch Med Sci ; 17(5): 1262-1276, 2021.
Article in English | MEDLINE | ID: covidwho-1403982
ABSTRACT

INTRODUCTION:

We aimed to examine the change in the number and severity of visits to the emergency departments (EDs) and subsequent admissions for urgent urologic conditions in the early stage of the coronavirus disease 2019 (COVID-19) pandemic in Poland. MATERIAL AND

METHODS:

We evaluated data from 13 urologic centers in Poland and compared the number of visits to the EDs and subsequent admissions before and after the advent of COVID-19 in 2020, and before and after the escalating national restrictions. Furthermore, data on types of urologic complaints, crucial laboratory parameters, and post-admission procedures were analyzed.

RESULTS:

In total 1,696 and 2,187 urologic visits (22.45% decrease) and 387 and 439 urologic urgent admissions (11.85% decrease) were reported in given periods in 2020 and 2019, respectively. The year-over-year difference in daily mean visits was clear (36.1 vs. 46.5; p < 0.001). Declines were seen in all complaints but device malfunction. In 2020 daily mean visits and admissions decreased from 40.9 and 9.6 before lockdowns to 30.9 (p < 0.001) and 6.9 (p = 0.001) after severe restrictions, respectively. There was a trend towards more negative laboratory parameter profiles in 2020, with patients who visited the EDs after severe restrictions having twice as high median levels of C-reactive protein (15.39 vs. 7.84, p = 0.03).

CONCLUSIONS:

The observed declines in ED visits and admissions were apparent with the significant effect of national lockdowns. Our results indicate that some of the patients requiring urgent medical help did not appear at the ED or came later than they would have done before the pandemic, presenting with more severe complaints.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: Arch Med Sci Year: 2021 Document Type: Article Affiliation country: Aoms.2020.98364

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: Arch Med Sci Year: 2021 Document Type: Article Affiliation country: Aoms.2020.98364